German court rules against Lilly in Alimta vitamin regimen patent lawsuit
The German Court of Appeal has ruled that Eli Lilly's vitamin regimen patent for Alimta® (pemetrexed disodium) would not be infringed by a generic competitor that intends to market a dipotassium salt form of pemetrexed in Germany once the compound patent expires in December 2015. March 06, 2015